These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 32702128)
1. Drug-induced aseptic meningitis in a Ph+ ALL patient with meningeal involvement. Beaumont AL; Suner L Blood; 2020 Jul; 136(4):520. PubMed ID: 32702128 [No Abstract] [Full Text] [Related]
2. Aseptic meningitis in a child after systemic treatment with high dose cytarabine. Pease CL; Horton TM; McClain KL; Kaplan SL Pediatr Infect Dis J; 2001 Jan; 20(1):87-9. PubMed ID: 11176579 [TBL] [Abstract][Full Text] [Related]
3. [Intrathecal chemotherapy in acute lymphoblastic leukemia. Prospective evaluation of toxicity using a combination employed in Mexico]. Gómez-Almaguer D; Almaguer-Gaona C; Mora-Brondo P; González-Llano O; Marfil-Rivera J; Villarreal G Rev Invest Clin; 1988; 40(2):129-33. PubMed ID: 3175366 [No Abstract] [Full Text] [Related]
4. Re: Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia. Chamberlain MC; Glantz MJ Blood; 2007 Sep; 110(5):1698; author reply 1698-9. PubMed ID: 17712051 [No Abstract] [Full Text] [Related]
5. Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma. Moser AM; Adamson PC; Gillespie AJ; Poplack DG; Balis FM Cancer; 1999 Jan; 85(2):511-6. PubMed ID: 10023723 [TBL] [Abstract][Full Text] [Related]
6. Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Short NJ; Jabbour E; Sasaki K; Patel K; O'Brien SM; Cortes JE; Garris R; Issa GC; Garcia-Manero G; Luthra R; Thomas D; Kantarjian H; Ravandi F Blood; 2016 Jul; 128(4):504-7. PubMed ID: 27235138 [TBL] [Abstract][Full Text] [Related]
7. Cytarabine induced noncardiogenic pulmonary edema in a case of acute lymphoblastic leukemia. Yegin ZA; Aki S; Sucak G; Yagci M Int J Lab Hematol; 2007 Dec; 29(6):482-3. PubMed ID: 17988309 [No Abstract] [Full Text] [Related]
9. Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia. von der Weid NX; de Crousaz H; Beck D; Deonna T; Miklossy J; Janzer RC Med Pediatr Oncol; 1991; 19(3):192-8. PubMed ID: 2023567 [TBL] [Abstract][Full Text] [Related]
10. Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia. Jabbour E; O'Brien S; Kantarjian H; Garcia-Manero G; Ferrajoli A; Ravandi F; Cabanillas M; Thomas DA Blood; 2007 Apr; 109(8):3214-8. PubMed ID: 17209054 [TBL] [Abstract][Full Text] [Related]
11. Optimizing the use of the hyperCVAD regimen: Clinical vignettes and practical management. Rausch CR; Jabbour EJ; Kantarjian HM; Kadia TM Cancer; 2020 Mar; 126(6):1152-1160. PubMed ID: 31794095 [No Abstract] [Full Text] [Related]
12. Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Ravandi F; O'Brien SM; Cortes JE; Thomas DM; Garris R; Faderl S; Burger JA; Rytting ME; Ferrajoli A; Wierda WG; Verstovsek S; Champlin R; Kebriaei P; McCue DA; Huang X; Jabbour E; Garcia-Manero G; Estrov Z; Kantarjian HM Cancer; 2015 Dec; 121(23):4158-64. PubMed ID: 26308885 [TBL] [Abstract][Full Text] [Related]
13. High-dose cytarabine-based therapy in adults with acute lymphoblastic leukemia. Feldman EJ Leuk Res; 2000 Mar; 24(3):189-91. PubMed ID: 10739000 [No Abstract] [Full Text] [Related]
15. The effect of cerebral spinal fluid replacement on acute myelopathy induced by intrathecal therapy of leukemia. Wang Z; Xu W; Liu L; Ding Z Leuk Res; 2011 Jun; 35(6):e79-80. PubMed ID: 21247632 [No Abstract] [Full Text] [Related]
16. Pure motor lumbosacral radiculopathy after intrathecal chemotherapy. Santos-García D; Pardo J; Vázquez F; Rabuñal-Martínez MJ; Martín-Vigo AI; de la Fuente-Fernández R Eur J Neurol; 2008 Aug; 15(8):e86-7. PubMed ID: 18549396 [No Abstract] [Full Text] [Related]
17. Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Land VJ; Shuster JJ; Crist WM; Ravindranath Y; Harris MB; Krance RA; Pinkel D; Pullen DJ J Clin Oncol; 1994 Sep; 12(9):1939-45. PubMed ID: 8083715 [TBL] [Abstract][Full Text] [Related]
18. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia. Winick N; Shuster JJ; Bowman WP; Borowitz M; Farrow A; Jacaruso D; Buchanan GR; Kamen BA J Clin Oncol; 1996 Oct; 14(10):2803-11. PubMed ID: 8874342 [TBL] [Abstract][Full Text] [Related]
19. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia. Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E; Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744 [TBL] [Abstract][Full Text] [Related]
20. Ventral polyradiculopathy with pediatric acute lymphocytic leukemia. Anderson SC; Baquis GD; Jackson A; Monteleone P; Kirkwood JR Muscle Nerve; 2002 Jan; 25(1):106-10. PubMed ID: 11754193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]